Quarterly ResultAug 5, 2026, 04:18 PM
KORU Medical Q2 Net Revenue +18.2% to $12.0M; Returns to Profit
AI Summary
KORU Medical Systems reported a strong second quarter 2026, with net revenues increasing by 18.2% to $12.0 million and the company returning to a net profit of $0.25 million, or $0.01 EPS, compared to a net loss in the prior year. For the first six months, net revenues grew 20.1% to $23.8 million, and the net loss significantly narrowed. The company also amended its loan agreement, extending maturities and lowering the interest rate floor, and acquired intangible assets.
Key Highlights
- Q2 2026 net revenues increased 18.2% to $12.0 million.
- Q2 2026 net income was $0.25 million, or $0.01 basic EPS, reversing a prior year loss.
- H1 2026 net revenues grew 20.1% to $23.8 million.
- International revenues surged 67.2% in Q2 and 51.2% in H1 2026.
- Loan agreement amended: revolver maturity extended to March 2028, term loan to Dec 2029.
- Interest rate floor lowered to 5.50% for both revolver and term loan.
- Acquired intangible assets for $0.96 million, partly settled with stock.
- CEO Linda Tharby retired on June 30, 2026, transitioning to an advisory role.
- Gross profit for Q2 2026 increased 21.2% to $7.8 million.
Price Impact
More from KRMD
Quarterly ResultAug 5, 4:13 PM
KORU Medical Systems Q2 Revenue $12.0M, Net Income $0.25M; Updates 2026 Guidance
PartnershipJun 30, 5:02 PM
KORU Medical Extends Manufacturing Agreement to 2031, Adds Second Site
Quarterly ResultMay 6, 4:10 PM
KORU Medical Q1 Revenue +22.1% to $11.8M; Net Loss Narrows to $0.8M